Press release
Lower Back Pain Market 2020 Growth Factors, Opportunities, Ongoing Trends and Key Players Pfizer Inc., Johnson & Johnson Services, Inc., Sanofi, Endo Pharmaceuticals Inc., Merck & Co., Inc
Lower Back Pain Market
Complete study compiled with over 100+ pages, list of tables & figures, profiling 10+ companies. Ask for Sample @https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-lower-back-pain-market&skp
Major Market Competitors/Players
Few of the major competitors currently working in the global lower back pain market are Pfizer Inc., Johnson & Johnson Services, Inc., Sanofi, Endo Pharmaceuticals Inc., Merck & Co., Inc., Dr. Reddy's Laboratories Ltd., Vertebral Technologies, Inc., Medtronic, Boston Scientific Corporation, BioWave Corporation, Koninklijke Philips N.V., Stayble Therapeutics AB, Axsome Therapeutics, Inc. , Mesoblast Ltd, ALLERGAN, Frontier Biotechnologies Inc., Astellas Pharma Inc., SpineThera, Inc., CELGENE CORPORATION, Teva Pharmaceutical Industries Ltd. among others.
Low back pain (LBP) is a type of muscle tension, musculoskeletal pain, or rigidity located above the gluteal sulcus and below the bottom edge of rib cage. The low back pain can be of three types: acute, sub-acute and chronic. Numerous disorders and diseases which disturb the lumbar region of the spine can cause this type of pain. According to the National Institute of Neurological Disorders and Stroke 2019 report approximately 80 percent adults experience this type of low back pain at some point of time in their lifetimes. According to the American Chiropractic Association report, America spends approximately USD 50,000 million in health care for the low-back pain each year.
Market Drivers:
o Inactive lifestyle is expected to drive the growth of the market
o Rising nerve cases can act as a market driver
o Rising use of emerging antidepressants is expected to boost the growth of this market
o Increasing geriatric population also enhances the market growth
Market Restraints:
o Unfavourable results of medications is expected to restrict the growth of the market
o Stringent regulatory policies, is restricting the overall adoption of these meters
o Unavailability of the medication is expected to restrict the growth of the market
Segmentation: Global Lower Back Pain Market
By Type of Disease
o Acute
o Sub-Acute
o Chronic
By Type
o Diagnosis
o Treatment
By End-User
o Hospitals
o Orthopaedic Clinics
o Ambulatory Surgery Centres
o Others
By Distribution Channel
o Direct
o Retail
By Geography
o North America
o Europe
o Asia-Pacific
o South America
o Middle East and Africa
Key Developments in the Market:
o In July 2018, Pfizer Inc. and Eli Lilly and Company received FDA approval for its tanezumab which can be used in the treatment of chronic low back pain (CLBP) and chronic pain of osteoarthritis (OA) patients. Tanezumab is a new humanized monoclonal antibody. This drug binds and inhibits nerve growth factor (NGF). This is the first NGF inhibitor which has received the Fast Track designation for serious conditions
o In July 2016, Relievant Medsystems, Inc. received FDA approval for its Intracept intraosseous nerve ablation system. This device is specially designed to treat chronic lower back pain. This product approval has created a milestone for the company
Competitive Analysis
Global lower back pain market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of lower back pain market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.
Table of Content: Global Lower Back Pain Market :-
Part 01: Executive Summary
Part 02: Scope of The Report
Part 03: Global Lower Back Pain Market Landscape
Part 04: Global Lower Back Pain Market Sizing
Part 05: Global Lower Back Pain Market Segmentation by Product
Part 06: Five Forces Analysis
Part 07: Customer Landscape
Part 08: Geographic Landscape
Part 09: Decision Framework
Part 10: Drivers and Challenges
Part 11: Market Trends
Part 12: Vendor Landscape
Part 13: Vendor Analysis
Continue....
Table Of Contents Is Available Here@https://www.databridgemarketresearch.com/toc/?dbmr=global-lower-back-pain-market&skp
Report Highlights : Lower Back Pain Market
Detailed overview of parent market (Lower Back Pain Market)
Market dynamics in the Lower Back Pain market
In-depth Lower Back Pain market segmentation
Historical, current, and projected Lower Back Pain market size in terms of volume and value
Recent industry trends and developments in the global Lower Back Pain market
Competitive landscape
Strategies of key players and products offered in the global Lower Back Pain market
Potential and niche segments, geographical regions exhibiting promising growth
A neutral perspective on Lower Back Pain market performance
Must-have information for market players in Lower Back Pain market to sustain and enhance their market footprint.
To Get This Report at an Attractive Cost, Click @ https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-lower-back-pain-market&skp
Reasons to Purchase this Lower Back Pain Market Report:
Current and future of global Lower Back Pain market outlook in the developed and emerging markets
The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
Regions/Countries that are expected to witness the fastest growth rates during the forecast period
The latest developments, market shares, and strategies that are employed by the major market players
Key Questions Answered
Who are the Leading key players and what are their Key Business plans in the Global Lower Back Pain market?
What are the key concerns of the five forces analysis of the Global Lower Back Pain market?
What are different prospects and threats faced by the dealers in the Global Lower Back Pain market?
What are the strengths and weaknesses of the key vendors?
Contact Us:
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email:Corporatesales@databridgemarketresearch.com
About Data Bridge Market Research:
Data Bridge Market Research is a versatile market research and consulting firm with over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Our coverage of industries include Medical Devices, Pharmaceuticals, Biotechnology, Semiconductors, Machinery, Information and Communication Technology, Automobiles and Automotive, Chemical and Material, Packaging, Food and Beverages, Cosmetics, Specialty Chemicals, Fast Moving Consumer Goods, Robotics, among many others.
Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude.We are content with our glorious 99.9 % client satisfying rate.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Lower Back Pain Market 2020 Growth Factors, Opportunities, Ongoing Trends and Key Players Pfizer Inc., Johnson & Johnson Services, Inc., Sanofi, Endo Pharmaceuticals Inc., Merck & Co., Inc here
News-ID: 2005788 • Views: …
More Releases from databridgemarketresearch
Medical Electronics Market to Exhibit a Remarkable CAGR of 8% by 2029, Size, Sha …
The medical electronics market is expected to witness market growth at a rate of 8% in the forecast period of 2022 to 2029.
Market Definition:
Medical electronics is referred to as a particular discipline that assimilates engineering with fields including clinical practice and biomedical sciences. Unlike paper records, medical electronics provides more advantages. Further allowing an individual track information over time it enhances the quality of patient care.
Download Sample PDF Copy…
Surgical Sponges Market to Exhibit a Remarkable CAGR of 3.60% by 2029, Size, Sha …
Data Bridge Market Research analyses that the surgical sponges market which was USD 2221.91 million in 2021, would rocket up to USD 2948.52 million by 2029, and is expected to undergo a CAGR of 3.60% during the forecast period 2022 to 2029.
Market Definition:
A surgical sponge is a specific type of cotton pad that is employed in surgeries to absorb blood and other bodily fluid flow. These sponges are useful for…
Antifibrinolytic Market to Exhibit a Remarkable CAGR of 5% by 2029, Size, Share, …
Data Bridge Market Research analyses a growth rate in the global antifibrinolytic market in the forecast period 2022-2029. The expected CAGR of global antifibrinolytic market is tend to be around 5% in the mentioned forecast period.
Market Definition:
Antifibrinolytic are a type of therapeutics that helps in blood clotting by restricting the process called fibrinolysis. Many antifibrinolytics such as tranexamic acid exert their action by reversibly binding to the lysine receptor…
Oxygen Delivery Systems Market to Exhibit a Remarkable CAGR of 6.3% by 2029, Siz …
Data Bridge Market Research analyses that the oxygen delivery systems market which was USD 12,949.38 million in 2021, is expected to reach USD 21111.31 million by 2029, at a CAGR of 6.3% during the forecast period 2022 to 2029.
Market Definition:
A device used to help, regulate, and supplement oxygen to patients in order to increase arterial oxygenation is known as an oxygen delivery system. Oxygen delivery systems provide oxygen therapy, which…
More Releases for Pain
Global Pain Management Devices Market Study Analysis: Adoption Of Pain Managemen …
The fast-food market size was valued at $ billion in 2020 and is estimated to reach $ billion by 2028, growing at a CAGR of 6.3% during the forecast period. Pain is an unpleasant sensation and emotional experience caused due to actual or potential tissue damage or illness. Pain can be caused due to accidental injuries, or due to diseases like osteoarthritis, chronic arthritis, diabetic neuropathy, multiple sclerosis, stomach ulcer,…
Flexotone Joint Pain Relief Reviews: Get Relief from Joint Pain & Arthritis
Joint pain & inflammation has come to be an instead usual problem among older consumers, as well as they are frequently entrusted to identify exactly how to deal with these problems with a topical cream or resting. Nevertheless, the makers behind Flexotone think that the reason behind this concern has every little thing to do with something that takes place within the joints. This trouble triggers unbelievable pain; however Big…
Nerve Pain Treatment: 3 Top Neuropathy Pain Relief Pills
Neuropathy affects your extremities or nerves by producing tingling, discomfort, or numbness. Diabetics frequently suffer from neuropathy. According to the American Diabetes Association, around 65 percent of people suffering from diabetes face varying degrees of nerve damage, which results in diabetic neuropathy.
Neuropathy can also occur due to different reasons, like alcoholism, trauma, or autoimmune disorders. Some people acquire neuropathy due to physical injury to their nerves, for instance. Others have…
Post-operative Pain Management Market 2018 by Pain Type - Acute Pain, Moderate P …
Post-operative Pain Management Market 2018 Research Report implements an exhaustive study on Market Research Future. This Report Cover Key Market Driver, market size, growth rate, opportunities, market Dynamics and Overall Analysis. And also cover the other information such as Post-operative Pain Management Market trends, Prominent players, chapter-wise Description followed by various user perceptions and Forecast till 2023.
Global Post-operative Pain Management Market - Overview
Post-operative pain management is the most important part…
Opioids – Reducing body pain but increasing pain for regulatory authorities
Opioids are drugs primarily prescribed for pain management and treatment of diarrhea and cough. Opioid drugs are of two types namely, agonist and antagonist. Codeine, Fentanyl, Meperidine, Methadone, Morphine, Hydrocodone, Diphenoxylate, Hydromorphone, Methylphenidate, Oxycodone, and Oxymorphone are classified as agonists, while Buprenorphine, Naloxone, Naltrexone, Methylnaltrexone, and Nalbuphine are classified as antagonists. Due to easy availability of opioids, these drugs are rampantly overused globally and the situation is more critical in…
Middle East Tapentadol Market by Therapeutic Application Pain Management Neuropa …
Tapentadol is an opioid analgesic, indicated for severe pain management, on a daily or around the clock need for treatment and long-term opioid treatment, for which alternative treatment options are inadequate. Tapentadol is also indicated for neuropathic pain associated with diabetic peripheral neuropathy. It is widely used for management of acute, chronic, and cancer related pain among patients and is available legally on prescription. Nucynta ER is the first and…
